每日影像引导对前列腺癌放疗计划质量及正常组织毒性的影响
该研究基于50例前列腺癌患者治疗计划,模拟不同每日IGRT场景对计划质量和正常组织并发症概率(NTCP)的影响。结果显示每日1MV-CBCT引入额外剂量并增加直肠NTCP,而每日kV-CBCT影响可忽略,若无kV设备则每周一次CBCT加平面图像优于每日MV-CBCT。
要点
- 每日kV-CBCT对计划质量和危及器官保护影响可忽略,推荐临床常规使用。
- 每日1MV-CBCT可增加高达两次分次剂量,导致部分DVH约束无法满足并增加直肠NTCP。
- 无kV设备时,每周一次CBCT加其余日平面图像应优先于每日MV-CBCT。
核心结论
- 每日kV-CBCT对计划质量影响可忽略,值得临床常规推荐。
- 若无kV设备,每周一次CBCT加其余日平面轴向图像应优先于每日MV-CBCT。
研究设计与样本
- 基于50例前列腺癌患者治疗计划,评估临床执行的IGRT并模拟不同每日IGRT场景对计划质量的影响。
- 将三种能量(6 MV、1 MV和121 kV)的平面和锥形束CT(CBCT)成像剂量加入治疗计划。
- 通过剂量分布和剂量体积直方图(DVH)视觉检查及DVH标准统计分析评估计划质量,并进行正常组织并发症概率(NTCP)评估。
主要发现
- 每日1MV-CBCT在靶区产生不期望的高剂量区域。
- 实际执行的IGRT、每日kV-CBCT和每日6MV成像(每周1次CBCT、4次平面图像)场景与原始计划差异不大,尤其每日kV-CBCT对危及器官保护影响很小。
- 每日1MV-CBCT带来高达两次分次剂量的额外剂量,导致部分计划可接受性DVH约束无法满足,并增加直肠NTCP。
关键数值与推荐
- 每日1MV-CBCT额外剂量高达两次分次剂量,部分DVH约束无法满足,直肠NTCP增加。
- 每日kV-CBCT对危及器官保护影响很小。
- 每日6MV成像(每周1次CBCT、4次平面图像)与原始计划差异不大。
临床怎么用
- 临床常规IGRT可优先选择每日kV-CBCT。
- 若无kV设备,可采用每周一次CBCT加其余日平面轴向图像,避免每日MV-CBCT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Modern radiotherapy offers various possibilities for image guided verification of patient positioning. Different clinically relevant IGRT (image guided radiotherapy) scenarios were considered with regard to their influence on dosimetric plan quality and normal tissue complication probability (NTCP). METHODS: This study is based on treatment plans of 50 prostate patients. We evaluate the clinically performed IGRT and simulate the influence of different daily IGRT scenarios on plan quality. Imaging doses of planar and cone-beam-CT (CBCT) images for three different energies (6 MV, 1 MV and 121 kV) were added to the treatment plans. The plan quality of the different scenarios was assessed by a visual inspection of the dose distribution and dose-volume-histogram (DVH) and a statistical analysis of DVH criteria. In addition, an assessment of the normal tissue complication probability was performed. RESULTS: Daily 1MV-CBCTs result in undesirable high dose regions in the target volume. The DVH shows that the scenarios with actual imaging performed, daily kV-CBCT and daily 6MV imaging (1x CBCT, 4x planar images per week) do not differ exceedingly from the original plan; especially imaging with daily kV-CBCT has little influence to the sparing of organs at risk. In contrast, daily 1MV- CBCT entails an additional dose of up to two fraction doses. Due to the additional dose amount some DVH constraints for plan acceptability could no longer be satisfied, especially for the daily 1MV-CBCT scenario. This scenario also shows increased NTCP for the rectum. CONCLUSION: Daily kV-CBCT has negligible influence on plan quality and is commendable for the clinical routine. If no kV-modality is available, a daily IGRT scenario with one CBCT per week and planar axial images on the other days should be preferred over daily MV-CBCT.
引用
- Bell K, Heitfeld M, Licht N, et al. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy. Radiat Oncol. 2017. PMID: 28069053. doi:10.1186/s13014-016-0757-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。